Table 4.
Organ utilization in the placebo versus albuterol groups
| Placebo | Albuterol | P value | |
|---|---|---|---|
| Lung | 78/246 (32%) | 74/260 (29%) | 0.44 |
| Lung (excluding donors less likely to donate)1 | 67/183 (37%) | 61/167 (37%) | 1.0 |
| Heart | 99/246 (40%) | 95/260 (37%) | 0.41 |
| Liver | 198/246 (81%) | 213/260 (82%) | 0.73 |
| Pancreas | 68/246 (28%) | 53/260 (20%) | 0.061 |
| Kidney | 216/246 (88%) | 199/260 (77%) | 0.001 |
| Kidney (excluding donors less likely to donate)2 | 138/143 (97%) | 121/130 (93%) | 0.27 |
1
Donors less likely to donate included those > 65 years old or > 50 pack years smoking or history of chronic lung disease or positive serologies
2
Donors less likely to donate included those with diabetes, chronic kidney disease, hypertension or positive serologies